Vasundhara Rasy.

29
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE406F01010
  • NSEID:
  • BSEID: 538634
INR
149.90
4.5 (3.09%)
BSENSE

Feb 04

BSE+NSE Vol: 133

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -8.18% vs -2.43% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -36.08% vs 15.73% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 57.56% vs -13.83% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -27.53% vs 4.80% in Mar 2024

Compare Profit and Loss Results of Vasundhara Rasy.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
33.00
104.00
-71.00
-68.27%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
33.00
104.00
-71.00
-68.27%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-4.00
4.00
100.00%
Raw Materials Consumed
15.00
79.00
-64.00
-81.01%
Power & Fuel Cost
0.00
7.00
-7.00
-100.00%
Employee Cost
3.00
6.00
-3.00
-50.00%
Operating Expenses
3.00
7.00
-4.00
-57.14%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
0.00
1.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
29.00
102.00
-73.00
-71.57%
Operating Profit (PBDIT) excl Other Income
4.00
2.00
2.00
100.00%
Other Income
2.00
0.00
2.00
0%
Operating Profit (PBDIT)
6.00
2.00
4.00
200.00%
Interest
0.00
1.00
-1.00
-100.00%
Profit before Depriciation and Tax
6.00
0.00
6.00
0%
Depreciation
0.00
10.00
-10.00
-100.00%
Profit Before Taxation & Exceptional Items
5.00
-10.00
15.00
150.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
5.00
-19.00
24.00
126.32%
Provision for Tax
1.00
2.00
-1.00
-50.00%
Profit After Tax
4.00
-21.00
25.00
119.05%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
28.00
-25.00
53.00
212.00%
Profit Available for appropriations
32.00
-47.00
79.00
168.09%
Appropriations
32.00
-47.00
79.00
168.09%
Equity Dividend (%)
20%
0%
20.00
Earnings Per Share
13.36
-4.34
17.70
407.83%
Profit And Loss - Net Sales
Net Sales 33.99 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -8.18% vs -2.43% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.11 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -36.08% vs 15.73% in Mar 2024

Profit And Loss - Interest
Interest 0.34 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 57.56% vs -13.83% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 4.25 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -27.53% vs 4.80% in Mar 2024